Technical Analysis for NVUS - Novus Therapeutics, Inc.

Grade Last Price % Change Price Change
grade F 0.6919 0.28% 0.00
NVUS closed up 0.28 percent on Friday, January 17, 2020, on 1.91 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Down
Historical NVUS trend table...

Date Alert Name Type % Chg
20 DMA Support Bullish 0.00%
50 DMA Support Bullish 0.00%
Calm After Storm Range Contraction 0.00%
Doji - Bullish? Reversal 0.00%
Outside Day Range Expansion 0.00%
Wide Bands Range Expansion 0.00%
Calm After Storm Range Contraction 0.28%
Wide Bands Range Expansion 0.28%
Calm After Storm Range Contraction -3.57%
Wide Bands Range Expansion -3.57%

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile

Novus Therapeutics, Inc., formerly Tokai Pharmaceuticals, Inc., is a pharmaceutical company. The Company is focused on the acquisition, development, and commercialization of ear, nose, and throat products. It has two platforms: OP-01 Foam Platform and OP-02 Surfactant Program. OP-01 is developed with the intent to be used as a delivery vehicle for drugs treating ears, as well as the nasal and sinus cavities. OP-01 is currently being developed as an improved treatment option for acute otitis externa. OP-02 is a daily nasal spray that is designed to improve and maintain a healthy middle ear. OP-02 is being developed as a potential treatment option for patients with otitis media and Eustachian tube dysfunction. OP-02 is a combination drug product, which comprises two components: surfactant dipalmitoylphosphatidylcholine and a spreading agent cholesteryl palmitate. The product is sprayed through the nostrils toward the opening of the Eustachian tube at the back of the nasal cavity.
Medicine Pharmaceutical Otorhinolaryngology Audiology Ear Pediatrics

Is NVUS a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 5.21
52 Week Low 0.4
Average Volume 113,539
200-Day Moving Average 1.19
50-Day Moving Average 0.64
20-Day Moving Average 0.67
10-Day Moving Average 0.74
Average True Range 0.10
ADX 41.81
+DI 25.80
-DI 15.09
Chandelier Exit (Long, 3 ATRs ) 0.70
Chandelier Exit (Short, 3 ATRs ) 0.79
Upper Bollinger Band 0.87
Lower Bollinger Band 0.47
Percent B (%b) 0.55
BandWidth 60.59
MACD Line 0.04
MACD Signal Line 0.04
MACD Histogram 0.0007
Fundamentals Value
Market Cap 4.8 Million
Num Shares 6.94 Million
EPS -3.46
Price-to-Earnings (P/E) Ratio -0.20
Price-to-Sales 0.00
Price-to-Book 1.14
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.86
Resistance 3 (R3) 0.86 0.81 0.84
Resistance 2 (R2) 0.81 0.76 0.81 0.83
Resistance 1 (R1) 0.75 0.73 0.78 0.75 0.82
Pivot Point 0.69 0.69 0.71 0.69 0.69
Support 1 (S1) 0.63 0.65 0.66 0.63 0.57
Support 2 (S2) 0.58 0.62 0.58 0.56
Support 3 (S3) 0.52 0.58 0.55
Support 4 (S4) 0.52